Skip to content
  • Sunday, 26 July 2026
  • 2:58 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • UK Life Sciences Sector Faces Funding Crisis Despite Government Prioritisation
Pharmaceutical R&D

UK Life Sciences Sector Faces Funding Crisis Despite Government Prioritisation

Teuku Ryan Jul 7, 2026 0

The United Kingdom’s ambitious plans to foster growth within its vital life sciences sector are facing significant headwinds, with industry…

Read More
Pharmaceutical R&D

The Biotech Sector Navigates a Shifting Landscape of Funding, Regulation, and Innovation

Teuku Ryan Jun 19, 2026 0

Following a significant investment slump that began after the initial surge of capital during the early COVID-19 pandemic, the biotechnology…

Read More
Pharmaceutical R&D

SpliSense Advances Promising Cystic Fibrosis Therapy with Significant Funding and Phase IIb Trial Launch

Teuku Ryan Jun 17, 2026 0

The biotech firm SpliSense is making significant strides in the development of a novel therapy for cystic fibrosis, announcing a…

Read More
Pharmaceutical R&D

Europe Must Rethink Funding and De-Risk Assets to Secure its Rare Disease Research Pipeline

Teuku Ryan Jun 13, 2026 0

The 13th European Conference on Rare Diseases and Orphan Products, held in Prague, Czech Republic, from June 3-4, 2026, served…

Read More
Pharmaceutical R&D

Contraline Secures $92.5 Million in Series B Funding to Advance Reversible Male Contraceptive to Late-Stage Clinical Trials

Teuku Ryan Jun 3, 2026 0

Contraline, a pioneering biotechnology firm backed by Google Ventures, has successfully closed a substantial $92.5 million Series B financing round.…

Read More
Pharmaceutical R&D

Protuoso Biosciences Secures $9.5 Million Seed Funding to Pioneer Multifunctional Biologics for Complex Diseases

Teuku Ryan May 27, 2026 0

Protuoso Biosciences, a burgeoning US-based biotechnology company, has successfully closed a $9.5 million seed financing round, positioning itself to revolutionize…

Read More
Pharmaceutical R&D

Isomorphic Labs Secures $2.1 Billion in Series B Funding to Accelerate AI-Driven Drug Discovery and Development

Teuku Ryan May 14, 2026 0

AI drug design and development firm Isomorphic Labs has successfully closed a significant $2.1 billion Series B funding round, marking…

Read More
Pharmaceutical R&D

Ray Therapeutics Secures $125 Million Series B Funding to Accelerate Vision Restoration Pipeline

Teuku Ryan Apr 22, 2026 0

Ray Therapeutics, a biopharmaceutical company at the forefront of developing novel gene therapies for vision restoration, has successfully closed a…

Read More
Biotech & Genetic Research

Cancer Scientists Unite at AACR Annual Meeting, Send Powerful Message to Congress on Sustained Research Funding

Jia Lissa Apr 22, 2026 0

On Sunday morning at the San Diego Convention Center, every attendee seated in Hall H for the Opening Ceremony and…

Read More
Biotech & Genetic Research

Cancer Scientists Unanimously Advocate for Sustained Congressional Funding at AACR Annual Meeting in San Diego

Jia Lissa Apr 21, 2026 0

On Sunday morning, at the bustling San Diego Convention Center, a powerful demonstration of unity and gratitude unfolded as attendees…

Read More

Posts pagination

1 2
Genetically Modified Hookworms Engineered as Living Drug Factories for Long-Term Therapeutic DeliveryTWiV 1290: Clinical Update with Dr. Daniel GriffinRethinking evidence generation for ultra-rare diseasesWhat if psilocybin works about as well for depression as an SSRI?
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ